141 related articles for article (PubMed ID: 35137416)
1. The role of exosomal miRNA in nonalcoholic fatty liver disease.
Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A
J Cell Physiol; 2022 Apr; 237(4):2078-2094. PubMed ID: 35137416
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and Nonalcoholic Steatohepatitis: A Review.
Morishita A; Oura K; Tadokoro T; Fujita K; Tani J; Kobara H; Ono M; Himoto T; Masaki T
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833930
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
Qi X; Lai J
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362287
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract][Full Text] [Related]
5. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
[TBL] [Abstract][Full Text] [Related]
6. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detection of Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma.
Rana M; Saini M; Das R; Gupta S; Joshi T; Mehta DK
Microrna; 2023; 12(2):99-113. PubMed ID: 37005546
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review.
Sun Y; Shen Y; Liang X; Zheng H; Zhang Y
Clin Ther; 2023 Mar; 45(3):234-247. PubMed ID: 36841739
[TBL] [Abstract][Full Text] [Related]
9. A narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer.
Jiang X; Wu S; Hu C
Int Immunopharmacol; 2023 Jul; 120():110284. PubMed ID: 37196562
[TBL] [Abstract][Full Text] [Related]
10. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications.
Doghish AS; Elballal MS; Elazazy O; Elesawy AE; Elrebehy MA; Shahin RK; Midan HM; Sallam AM
Pathol Res Pract; 2023 Mar; 243():154375. PubMed ID: 36801506
[TBL] [Abstract][Full Text] [Related]
11. Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes.
Zhao X; Kong X; Cui Z; Zhang Z; Wang M; Liu G; Gao H; Zhang J; Qin W
Eur J Pharm Sci; 2024 Feb; 193():106690. PubMed ID: 38181871
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of engineered exosomes in nonalcoholic fatty liver disease.
Ding J; Xu C; Xu M; He XY; Li WN; He F
World J Hepatol; 2023 Mar; 15(3):386-392. PubMed ID: 37034232
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNAs in autoimmune skin diseases.
Zhang R; Wei Y; Wang T; Nie X; Shi Z; Deng Y; Li D
Front Immunol; 2023; 14():1307455. PubMed ID: 38106405
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis.
Tang X; Leng M; Tang W; Cai Z; Yang L; Wang L; Zhang Y; Guo J
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542836
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: Small molecules with big impacts in liver injury.
Abdel Halim AS; Rudayni HA; Chaudhary AA; Ali MAM
J Cell Physiol; 2023 Jan; 238(1):32-69. PubMed ID: 36317692
[TBL] [Abstract][Full Text] [Related]
16. The Machinery of Exosomes: Biogenesis, Release, and Uptake.
Krylova SV; Feng D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674857
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ethanol on Exosome Biogenesis: Possible Mechanisms and Therapeutic Implications.
Sundar V; Saraswathi V
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830592
[TBL] [Abstract][Full Text] [Related]
18. Exosome and exosomal contents in schizophrenia.
Zhang T; Fang Y; Wang L; Gu L; Tang J
J Psychiatr Res; 2023 Jul; 163():365-371. PubMed ID: 37267733
[TBL] [Abstract][Full Text] [Related]
19. Emerging functions and clinical applications of exosomal microRNAs in diseases.
Ghafouri-Fard S; Shoorei H; Dong P; Poornajaf Y; Hussen BM; Taheri M; Akbari Dilmaghani N
Noncoding RNA Res; 2023 Sep; 8(3):350-362. PubMed ID: 37250456
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence.
Zhang J; Ma B; Wang Z; Chen Y; Li C; Dong Y
Cell Commun Signal; 2024 Jan; 22(1):18. PubMed ID: 38195552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
